Carlisle Companies Incorporated (CSL)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 767,400 736,100 725,200 832,100 924,000 877,900 765,300 563,100 421,700 374,200 334,400 310,500 320,100 342,100 377,700 455,200 472,800 458,300 420,100 380,900
Total assets US$ in thousands 6,620,000 6,816,000 7,176,200 7,115,400 7,222,000 7,732,000 7,577,700 7,323,000 7,246,800 7,074,600 5,839,300 5,752,200 5,866,400 5,800,000 5,808,300 6,297,600 5,496,000 5,541,100 5,396,700 5,301,700
ROA 11.59% 10.80% 10.11% 11.69% 12.79% 11.35% 10.10% 7.69% 5.82% 5.29% 5.73% 5.40% 5.46% 5.90% 6.50% 7.23% 8.60% 8.27% 7.78% 7.18%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $767,400K ÷ $6,620,000K
= 11.59%

Carlisle Companies Inc.'s return on assets (ROA) has shown a fluctuating trend over the past eight quarters. The ROA ranged between 7.69% and 12.79%, with the highest ROA reported in Q4 2022 at 12.79% and the lowest in Q1 2022 at 7.69%. Despite some volatility, the ROA generally remained above 10% for the majority of the periods, indicating that the company has been effectively utilizing its assets to generate profits. The average ROA over these eight quarters is approximately 10.93%, suggesting that Carlisle Companies Inc. has been efficient in generating earnings relative to its asset base over this time period. Further analysis of the company's financial performance and asset management strategies would be beneficial to assess the sustainability and growth potential of its ROA in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
ROA
Carlisle Companies Incorporated
CSL
11.59%
West Pharmaceutical Services Inc
WST
15.50%